肠道菌群及针刺调节与动脉粥样硬化防治
|
摘要
肠道菌群存在于肠道,多种微生物拮抗共生、动态平衡,一旦平衡破坏,可引起宿主发生多种疾病。脑-肠轴理论提出肠道菌群与焦虑、抑郁等情绪障碍也有关系。动脉粥样硬化是冠心病、脑卒中等多种心脑血管病变的病理基础,与肠道菌群组成改变及功能失调之间可能存在一定联系。肠道菌群同黏膜免疫相互作用,代谢产物氧化三甲胺可能对AS形成有影响,短链脂肪酸可影响危险因素的出现,增加AS发生。动脉粥样硬化可归属"胸痹""真心痛""血脉病""痰饮""中风"等范畴,为本虚标实,本虚为气、血、阴、阳虚,可累及心、肝、脾、肾;气滞、寒凝、痰阻、血瘀为标。肠道菌群与宿主生理相关、病理相互影响,与中医学天人相应、整体观理念一致,与阴阳学说、脾胃有异曲同工之处。针刺防治AS着眼于整体调节,对肠道菌群也有调节作用,辨证取穴,从痰、瘀、毒论治,整体调节脏腑功能,通过对大脑、肠道菌群、骨髓的整体调节,可能是AS防治效应机制。针灸影响肠道菌群数量与结构,恢复宿主肠道内环境动态平衡,是AS防治重要着眼点。未来高通量测序、高效液相色谱、气相色谱等为研究肠道菌群与针刺治疗动脉粥样硬化关系提供了技术保证。
Intestinal flora exists in the intestine, and various microorganisms antagonize symbiosis and dynamic balance. Once the balance is destroyed, various diseases may occur in the host. The brain-gut axis theory suggests that the intestinal flora is also associated with emotional disorders such as anxiety and depression. Atherosclerosis is the pathological basis of various cardiovascular and cerebrovascular diseases in coronary heart disease and stroke, and may be related to the changes in intestinal flora composition and dysfunction. Intestinal flora interacts with mucosal immune system, and the metabolite oxidized trimethylamine may affect the formation of AS. Short-chain fatty acids may affect the occurrence of risk factors and increase the incidence of AS. Atherosclerosis can be attributed to the categories of "chest", "true heart pain", "blood vein disease", "sip", "stroke", etc., which is a virtual standard, which is qi, blood, yin and yang, and can involve the heart. Liver, spleen, kidney; qi stagnation, cold coagulation, phlegm obstruction,blood stasis as the standard. The intestinal flora is related to the host's physiology and pathology. It is consistent with the traditional Chinese medicine and the overall concept, and has the same symmetry with the yin and yang theory and the spleen and stomach. Acupuncture prevention and treatment AS focuses on the overall regulation, and also has a regulating effect on the intestinal flora. The syndrome differentiation and acupoints are treated from sputum, sputum and poison, and the overall function of the viscera is regulated.Through the overall regulation of the brain, intestinal flora and bone marrow, May be the AS prevention effect mechanism. Acupuncture affects the number and structure of intestinal flora and restores the dynamic balance of the environment in the host intestinal tract. It is an important point of attention for AS prevention and treatment. Future high-throughput sequencing, high performance liquid chromatography, and gas chromatography provide technical guarantees for studying the relationship between intestinal flora and acupuncture for atherosclerosis.
Intestinal flora exists in the intestine, and various microorganisms antagonize symbiosis and dynamic balance. Once the balance is destroyed, various diseases may occur in the host. The brain-gut axis theory suggests that the intestinal flora is also associated with emotional disorders such as anxiety and depression. Atherosclerosis is the pathological basis of various cardiovascular and cerebrovascular diseases in coronary heart disease and stroke, and may be related to the changes in intestinal flora composition and dysfunction. Intestinal flora interacts with mucosal immune system, and the metabolite oxidized trimethylamine may affect the formation of AS. Short-chain fatty acids may affect the occurrence of risk factors and increase the incidence of AS. Atherosclerosis can be attributed to the categories of "chest", "true heart pain", "blood vein disease", "sip", "stroke", etc., which is a virtual standard, which is qi, blood, yin and yang, and can involve the heart. Liver, spleen, kidney; qi stagnation, cold coagulation, phlegm obstruction,blood stasis as the standard. The intestinal flora is related to the host's physiology and pathology. It is consistent with the traditional Chinese medicine and the overall concept, and has the same symmetry with the yin and yang theory and the spleen and stomach. Acupuncture prevention and treatment AS focuses on the overall regulation, and also has a regulating effect on the intestinal flora. The syndrome differentiation and acupoints are treated from sputum, sputum and poison, and the overall function of the viscera is regulated.Through the overall regulation of the brain, intestinal flora and bone marrow, May be the AS prevention effect mechanism. Acupuncture affects the number and structure of intestinal flora and restores the dynamic balance of the environment in the host intestinal tract. It is an important point of attention for AS prevention and treatment. Future high-throughput sequencing, high performance liquid chromatography, and gas chromatography provide technical guarantees for studying the relationship between intestinal flora and acupuncture for atherosclerosis.
引文
[1]Monda V,Villano I,Messina A,et al.Exercise Modifies the Gut Microbiota with Positive Health Effects[J].Oxid Med Cell Longev,2017,3(1972):5-8.
[2]李旻.人体肠道菌群结构与宿主代谢的相关性研究[D].上海交通大学,2009.
[3]田慧,杨琳,王娜.肠道微生态与代谢性疾病[J].中国老年学杂志,2018,38(19):4841-4844.
[4]齐静,郝欣,李建辉.肠道微生态与人体疾病关系的研究[J].世界最新医学信息文摘,2018,18(51):58-59.
[5]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[6]曲华,姜众会,杨巧宁,等.基于“心合小肠”论动脉粥样硬化与肠道微环境的关系[J].中医杂志,2018(23):2009-2012.
[7]阮晓枫,陈晓刚.动脉粥样硬化的肠道微生态机制研究[J].中国民族民间医药,2015,24(20):19-20.
[8]崔晨,成泽东.基于肠道菌群探讨针刺治疗心血管疾病的作用机制[J].光明中医,2018,33(7):939-941.
[9]邹远强.健康人肠道微生物菌种TF01-11~T的分类学研究[D].广州:华南理工大学,2016.
[10]Qin J,Li R,Raes J,et a1.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.
[11]Dethlefsen L,Mcfallngai M,Relman D A.An ecological and evolutionary perspective on human-microbe mutualism and disease[J].Nature,2007,449(7164):811-818.
[12]陈毅秋,石春卫,姜延龙,等.肠道菌群与B细胞发育的相互调节作用[J].中国免疫学杂志,2017,33(1):140-143.
[13]Backhed,F.Host-Bacterial Mutualism in the Human Intestine[J].Science(Washington D.C.),2005,307(5717):1915-1920.
[14]MARCHESI JR,ADAMS DH,FAVA F,et al.The gut microbiota and host health:a new clinical frontier[J].Gut,2016,65(2):330-339.
[15]CHO I,BLASER MJ.The human microbiome:at the interface of health and disease[J].Nat Rev Genet,2012,13(4):260-270.
[16]刘华,苟小军,曹健美.肠道菌群失调与慢性肝病[J].实用药物与临床,2017,(9):1098-1101.DOI:10.14053/j.cnki.ppcr.201709028.
[17]Koren O,Spor A,Felin J,et al.Human oral,gut and plaque microbiota in patients with atherosclerosis[J].Proc Natl Acad SciUSA,2011,108(Suppl1):4592-4598.DOI:10.1073/pnas.1011383107.
[18]Karlsson FH,Fk F,Nookaew I,et al.Symptomatic atherosclerosis is associated with an altered gut metagenome[J].NatCommun,2012,3:1245.DOI:10.1038/ncomms2266.
[19]Gabriel H B,Romero-Figueroa María del Socorro,MontielJarquín Alvaro José,et al.Intestinal Dysbiosis and Rheumatoid Arthritis:A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis[J].Journal of Immunology Research,2017,2017:1-13.
[20]Li J,Zhao F,Wang Y,et al.Gut microbiota dysbiosis contributes to the development of hypertension[J].Microbiome,2017,5(1):14.
[21]Curtiss,LK,Tobias PS.Emerging role of Toll-like receptors inatherosclerosis[J].J Lipid Res,2009,165(Suppl):S340-S345.
[22]高丽娜.Toll样受体4介导的巨噬细胞泡沫化与动脉粥样硬化[J].济宁医学院学报,2018,41(3):153-157.
[23]王燕萍,陈媛媛,吴丽苹,等.Toll样受体4参与调控脂质诱导的平滑肌细胞炎症反应的研究[J].诊断学理论与实践,2017,16(5):504-509.
[24]Tang WH,Hazen SL.The contributory role of gut microbiota incardiovascular disease[J].J Clin Invest,2016,124(10):4204-4211.
[25]George A.Kaysen,Kirsten L.Johansen,Glenn M.Chertow,et a1Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis[J].Journal of Renal Nutrition,2015,25(4):351-356.
[26]Tang W H W,Wang Z E,Levison B S.Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk[J].Journal of Vascular Surgery,2013,58(2):549.
[27]Ierardi E,Sorrentino C,Principi M,et al.Intestinal microbial metaboli sm of phosphatidy lcholine:a novel insight in the cardiovascular risk scenario[J].Hepatobiliary Surg Nutr,2015,4(4):289-292.
[28]He M,Shi B.Gut microbiota as a potential target of metabolic syndrome:the role of probiotics and prebiotics[J].Cell&Bioscience,2017,7(1):54.
[29]Kimura I,Ozawa K,Inoue D,et al.The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J].Nat Commun,2013,4:1829.
[30]饶翀,肖新华.肠道菌群和脂代谢异常[J].中华临床医师杂志(电子版),2016,10(8):1053-1055.
[31]Velagapudi VR,Hezaveh R,Reigstad CS,et al.The gut me-crobiota modulates host energy and lipid metabolism in mice[J].J Lipid Res,2010,51(5):1101-1112.
[32]Zhao L.The gut microbiota and obesity:from correlation to causality[J].Nature Reviews Microbiology,2013,11(9):639.
[33]Kim M H,Kang S G,Park J H,et al.Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice[J].Gastroenterology,2013,145(2):396-406.
[34]CANFORA EE,JOCKEN JW,BLAAK EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J].Nat Rev Endocrinol,2015,11(10):577-591.
[35]张艳达,贺治青,黄帅波,等.肠道菌群失调与动脉粥样硬化相关心血管疾病[J].国际心血管病杂志,2017,44(1):10-13.
[36]容祖华,梁少聪,路浚齐,等.间歇性断食对老年前期肥胖大鼠肠道菌群及代谢的影响[J].南方医科大学学报,2017,37(4):423-430.
[37]孔凡华,成泽东.肠道菌群失调的中医病机探讨[J].江西中医药大学学报,2016,28(6):6-7.
[38]蔡子微,康白.关于中医学与微生态学在原理上的统一性[J].中国微生态学杂志,1995(4):43-48.
[39]李德新.论中医学的整体观念[J].中医函授通讯,1984(1):10-11.
[40]武娜,朱宝利.人体肠道微生物与健康[J].科学,2013,65(2):13-16.
[41]张永红,王秀荣,魏林.抗生素相关性腹泻患者微生态治疗前后肠道菌群的定量检测[J].河北医科大学学报,2003(5):305-306.
[42]邵晓姣,成泽东.从中医阴阳五行理论谈肠道菌群[J].辽宁中医药大学学报,2013,15(7):136-137.
[43]王振宇,钱祥,石磊,张爱琴.从中医学角度看肠道菌群及其失调后的治疗[J].新中医,2017,49(2):147-149.
[44]刘昌孝.肠道菌群与健康、疾病和药物作用的影响[J].中国抗生素杂志,2018,43(1):1-14.
[45]张介宾.类经[M].北京:人民卫生出版社,1965:31.
[46]杜雅薇,吴圣贤.从“痰核”论治动脉粥样硬化稳定斑块[J].中国中医基础医学杂志,2018,24(8):1153-1155.
[47]韩景辉.动脉粥样硬化疾病的中医新认识[J].中医研究,2010,23(5):11-13.
[48]黄宝坤,李生鹏,王兴榆.基于痰瘀互结对动脉粥样硬化的认识[J].中西医结合心血管病电子杂志,2018,6(18):182.
[49]黄帝内经素问[M].田代华,整理.北京:人民卫生出版社,2015:188.
[50]齐锡友,董致郅,谢春荣.从病因病机谈颈动脉粥样硬化与痰浊的关系[J].北京中医药,2012,31(6):480-481.
[51]黄烨,殷惠军,陈可冀.心主血脉与血栓前状态[J].中华中医药杂志,2011,26(4):633-636.
[52]张介宾.景岳全书[M].太原:山西科学技术出版社,2006:274.
[53]陈章兴,戴益琛,谢军培,等.DNA指纹图谱在炎症性肠病肠道菌群分析中的价值[J].临床军医杂志,2013,41(9):955-956.
[54]Daniel N F,Allison L S A,Robert A F,et al.Molecular-phylogenetic characterization of microbialcommunity imbalances in human inflammatory bowel diseases[J].PANS,2007,104(34):13780-13785.
[55]冯文林,伍海涛.从肠道菌群探讨多种疾病从脾论治的机理[J].吉林中医药,2018,38(10):1124-1127.
[56]郑全理,杨飞丹.肠道菌群平衡在肠炎类疾病诊治中的意义[J].中国卫生工程学,2018,17(4):563-564.
[57]周逸平.关于经络经脉脏腑相关研究的深入探讨[J].针刺研究,2006(6):327-328.
[58]李景兴,李清.针灸治疗颈动脉粥样硬化的选穴规律探讨[J].湖南中医药大学学报,2018,38(8):934-938.
[59]何冬凤,任玉兰,唐勇,等.古代不同时期针灸治疗胸痹用穴特点的数据挖掘研究[J].辽宁中医杂志,2013,40(6):1209-1213.
[60]孙晓伟,栾仲秋,李洪涛,等.针刺对急性颈动脉粥样硬化性脑梗死患者血清MMP-9水平的影响[J].中医药信息,2015,32(6):66-68.
[61]朱守莲,李乐敬.针刺治疗颈动脉粥样硬化斑块疗效及对IL-10水平的影响[J].山东中医杂志,2015,34(6):438-440.
[62]陈松.电针“内关”预处理对心肌缺血再灌注大鼠p38MAPK信号通路的影响及机制研究[D].武汉:湖北中医药大学,2017.
[63]栾海燕,成泽东.针刺对动脉粥样硬化家兔炎症因子及氧化应激标志物的影响[J].中华中医药学刊,2018,36(6):1396-1398.
[64]林威.温针灸对实验性高脂血症大鼠血脂的影响及机制探讨[D].武汉:湖北中医药大学,2017.
[65]邓雪梅.针刺治疗单纯性肥胖的临床及实验研究[D].成都:成都中医药大学,2010.
[66]孔凡华.电针对动脉粥样硬化家兔肠道菌群的影响[D].沈阳:辽宁中医药大学,2017.
[67]王芮,成泽东.基于大脑-肠道-骨髓轴探讨针刺治疗心血管疾病[J].中西医结合心血管病电子杂志,2018,6(3):22-23.
[68]Jonsson A L,B?khed F.Role of gut microbiota in atherosclerosis[J].Nature Reviews Cardiology,2017,14(2):79.
[69]Pevsner-Fischer M,Blacher E,Tatirovsky E,et al.The gut microbiome and hypertension[J].Current Opinion in Nephrology&Hypertension,2017,26(1):1.
[70]李德新.中医基础理论[M].北京:科学出版社,2001:57
[2]李旻.人体肠道菌群结构与宿主代谢的相关性研究[D].上海交通大学,2009.
[3]田慧,杨琳,王娜.肠道微生态与代谢性疾病[J].中国老年学杂志,2018,38(19):4841-4844.
[4]齐静,郝欣,李建辉.肠道微生态与人体疾病关系的研究[J].世界最新医学信息文摘,2018,18(51):58-59.
[5]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[6]曲华,姜众会,杨巧宁,等.基于“心合小肠”论动脉粥样硬化与肠道微环境的关系[J].中医杂志,2018(23):2009-2012.
[7]阮晓枫,陈晓刚.动脉粥样硬化的肠道微生态机制研究[J].中国民族民间医药,2015,24(20):19-20.
[8]崔晨,成泽东.基于肠道菌群探讨针刺治疗心血管疾病的作用机制[J].光明中医,2018,33(7):939-941.
[9]邹远强.健康人肠道微生物菌种TF01-11~T的分类学研究[D].广州:华南理工大学,2016.
[10]Qin J,Li R,Raes J,et a1.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.
[11]Dethlefsen L,Mcfallngai M,Relman D A.An ecological and evolutionary perspective on human-microbe mutualism and disease[J].Nature,2007,449(7164):811-818.
[12]陈毅秋,石春卫,姜延龙,等.肠道菌群与B细胞发育的相互调节作用[J].中国免疫学杂志,2017,33(1):140-143.
[13]Backhed,F.Host-Bacterial Mutualism in the Human Intestine[J].Science(Washington D.C.),2005,307(5717):1915-1920.
[14]MARCHESI JR,ADAMS DH,FAVA F,et al.The gut microbiota and host health:a new clinical frontier[J].Gut,2016,65(2):330-339.
[15]CHO I,BLASER MJ.The human microbiome:at the interface of health and disease[J].Nat Rev Genet,2012,13(4):260-270.
[16]刘华,苟小军,曹健美.肠道菌群失调与慢性肝病[J].实用药物与临床,2017,(9):1098-1101.DOI:10.14053/j.cnki.ppcr.201709028.
[17]Koren O,Spor A,Felin J,et al.Human oral,gut and plaque microbiota in patients with atherosclerosis[J].Proc Natl Acad SciUSA,2011,108(Suppl1):4592-4598.DOI:10.1073/pnas.1011383107.
[18]Karlsson FH,Fk F,Nookaew I,et al.Symptomatic atherosclerosis is associated with an altered gut metagenome[J].NatCommun,2012,3:1245.DOI:10.1038/ncomms2266.
[19]Gabriel H B,Romero-Figueroa María del Socorro,MontielJarquín Alvaro José,et al.Intestinal Dysbiosis and Rheumatoid Arthritis:A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis[J].Journal of Immunology Research,2017,2017:1-13.
[20]Li J,Zhao F,Wang Y,et al.Gut microbiota dysbiosis contributes to the development of hypertension[J].Microbiome,2017,5(1):14.
[21]Curtiss,LK,Tobias PS.Emerging role of Toll-like receptors inatherosclerosis[J].J Lipid Res,2009,165(Suppl):S340-S345.
[22]高丽娜.Toll样受体4介导的巨噬细胞泡沫化与动脉粥样硬化[J].济宁医学院学报,2018,41(3):153-157.
[23]王燕萍,陈媛媛,吴丽苹,等.Toll样受体4参与调控脂质诱导的平滑肌细胞炎症反应的研究[J].诊断学理论与实践,2017,16(5):504-509.
[24]Tang WH,Hazen SL.The contributory role of gut microbiota incardiovascular disease[J].J Clin Invest,2016,124(10):4204-4211.
[25]George A.Kaysen,Kirsten L.Johansen,Glenn M.Chertow,et a1Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis[J].Journal of Renal Nutrition,2015,25(4):351-356.
[26]Tang W H W,Wang Z E,Levison B S.Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk[J].Journal of Vascular Surgery,2013,58(2):549.
[27]Ierardi E,Sorrentino C,Principi M,et al.Intestinal microbial metaboli sm of phosphatidy lcholine:a novel insight in the cardiovascular risk scenario[J].Hepatobiliary Surg Nutr,2015,4(4):289-292.
[28]He M,Shi B.Gut microbiota as a potential target of metabolic syndrome:the role of probiotics and prebiotics[J].Cell&Bioscience,2017,7(1):54.
[29]Kimura I,Ozawa K,Inoue D,et al.The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J].Nat Commun,2013,4:1829.
[30]饶翀,肖新华.肠道菌群和脂代谢异常[J].中华临床医师杂志(电子版),2016,10(8):1053-1055.
[31]Velagapudi VR,Hezaveh R,Reigstad CS,et al.The gut me-crobiota modulates host energy and lipid metabolism in mice[J].J Lipid Res,2010,51(5):1101-1112.
[32]Zhao L.The gut microbiota and obesity:from correlation to causality[J].Nature Reviews Microbiology,2013,11(9):639.
[33]Kim M H,Kang S G,Park J H,et al.Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice[J].Gastroenterology,2013,145(2):396-406.
[34]CANFORA EE,JOCKEN JW,BLAAK EE.Short-chain fatty acids in control of body weight and insulin sensitivity[J].Nat Rev Endocrinol,2015,11(10):577-591.
[35]张艳达,贺治青,黄帅波,等.肠道菌群失调与动脉粥样硬化相关心血管疾病[J].国际心血管病杂志,2017,44(1):10-13.
[36]容祖华,梁少聪,路浚齐,等.间歇性断食对老年前期肥胖大鼠肠道菌群及代谢的影响[J].南方医科大学学报,2017,37(4):423-430.
[37]孔凡华,成泽东.肠道菌群失调的中医病机探讨[J].江西中医药大学学报,2016,28(6):6-7.
[38]蔡子微,康白.关于中医学与微生态学在原理上的统一性[J].中国微生态学杂志,1995(4):43-48.
[39]李德新.论中医学的整体观念[J].中医函授通讯,1984(1):10-11.
[40]武娜,朱宝利.人体肠道微生物与健康[J].科学,2013,65(2):13-16.
[41]张永红,王秀荣,魏林.抗生素相关性腹泻患者微生态治疗前后肠道菌群的定量检测[J].河北医科大学学报,2003(5):305-306.
[42]邵晓姣,成泽东.从中医阴阳五行理论谈肠道菌群[J].辽宁中医药大学学报,2013,15(7):136-137.
[43]王振宇,钱祥,石磊,张爱琴.从中医学角度看肠道菌群及其失调后的治疗[J].新中医,2017,49(2):147-149.
[44]刘昌孝.肠道菌群与健康、疾病和药物作用的影响[J].中国抗生素杂志,2018,43(1):1-14.
[45]张介宾.类经[M].北京:人民卫生出版社,1965:31.
[46]杜雅薇,吴圣贤.从“痰核”论治动脉粥样硬化稳定斑块[J].中国中医基础医学杂志,2018,24(8):1153-1155.
[47]韩景辉.动脉粥样硬化疾病的中医新认识[J].中医研究,2010,23(5):11-13.
[48]黄宝坤,李生鹏,王兴榆.基于痰瘀互结对动脉粥样硬化的认识[J].中西医结合心血管病电子杂志,2018,6(18):182.
[49]黄帝内经素问[M].田代华,整理.北京:人民卫生出版社,2015:188.
[50]齐锡友,董致郅,谢春荣.从病因病机谈颈动脉粥样硬化与痰浊的关系[J].北京中医药,2012,31(6):480-481.
[51]黄烨,殷惠军,陈可冀.心主血脉与血栓前状态[J].中华中医药杂志,2011,26(4):633-636.
[52]张介宾.景岳全书[M].太原:山西科学技术出版社,2006:274.
[53]陈章兴,戴益琛,谢军培,等.DNA指纹图谱在炎症性肠病肠道菌群分析中的价值[J].临床军医杂志,2013,41(9):955-956.
[54]Daniel N F,Allison L S A,Robert A F,et al.Molecular-phylogenetic characterization of microbialcommunity imbalances in human inflammatory bowel diseases[J].PANS,2007,104(34):13780-13785.
[55]冯文林,伍海涛.从肠道菌群探讨多种疾病从脾论治的机理[J].吉林中医药,2018,38(10):1124-1127.
[56]郑全理,杨飞丹.肠道菌群平衡在肠炎类疾病诊治中的意义[J].中国卫生工程学,2018,17(4):563-564.
[57]周逸平.关于经络经脉脏腑相关研究的深入探讨[J].针刺研究,2006(6):327-328.
[58]李景兴,李清.针灸治疗颈动脉粥样硬化的选穴规律探讨[J].湖南中医药大学学报,2018,38(8):934-938.
[59]何冬凤,任玉兰,唐勇,等.古代不同时期针灸治疗胸痹用穴特点的数据挖掘研究[J].辽宁中医杂志,2013,40(6):1209-1213.
[60]孙晓伟,栾仲秋,李洪涛,等.针刺对急性颈动脉粥样硬化性脑梗死患者血清MMP-9水平的影响[J].中医药信息,2015,32(6):66-68.
[61]朱守莲,李乐敬.针刺治疗颈动脉粥样硬化斑块疗效及对IL-10水平的影响[J].山东中医杂志,2015,34(6):438-440.
[62]陈松.电针“内关”预处理对心肌缺血再灌注大鼠p38MAPK信号通路的影响及机制研究[D].武汉:湖北中医药大学,2017.
[63]栾海燕,成泽东.针刺对动脉粥样硬化家兔炎症因子及氧化应激标志物的影响[J].中华中医药学刊,2018,36(6):1396-1398.
[64]林威.温针灸对实验性高脂血症大鼠血脂的影响及机制探讨[D].武汉:湖北中医药大学,2017.
[65]邓雪梅.针刺治疗单纯性肥胖的临床及实验研究[D].成都:成都中医药大学,2010.
[66]孔凡华.电针对动脉粥样硬化家兔肠道菌群的影响[D].沈阳:辽宁中医药大学,2017.
[67]王芮,成泽东.基于大脑-肠道-骨髓轴探讨针刺治疗心血管疾病[J].中西医结合心血管病电子杂志,2018,6(3):22-23.
[68]Jonsson A L,B?khed F.Role of gut microbiota in atherosclerosis[J].Nature Reviews Cardiology,2017,14(2):79.
[69]Pevsner-Fischer M,Blacher E,Tatirovsky E,et al.The gut microbiome and hypertension[J].Current Opinion in Nephrology&Hypertension,2017,26(1):1.
[70]李德新.中医基础理论[M].北京:科学出版社,2001:57
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |